SBI Securities
IMNM icon

SBI Securities’s Immunome IMNM Stock Holding History

SBI Securities’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$237 Buy
11
+1
+10% +$25 ﹤0.01% 3359
2026
Q2 		$212 Sell
10
-6
-38% -$128 ﹤0.01% 3309
2026
Q1 		$350 Buy
16
+7
+78% +$156 ﹤0.01% 3021
2025
Q4 		$193 Sell
9
-14
-61% -$246 ﹤0.01% 3221
2025
Q3 		$269 Sell
23
-47
-67% -$468 ﹤0.01% 3219
2025
Q2 		$651 Buy
70
+20
+40% +$164 ﹤0.01% 2853
2025
Q1 		$337 Buy
50
+26
+108% +$249 ﹤0.01% 3024
2024
Q4 		$255 Buy
+24
New +$290 ﹤0.01% 3156

Other funds holding IMNM

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Maltin Wealth Management
Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

SBI Securities's IMNM Position: Q3 2026 in Review

SBI Securities increased its Immunome (IMNM) stake by 10% in Q3 2026, buying an estimated $25 and bringing the position to 11 shares worth $237. The position accounts for ﹤0.01% of the portfolio, ranked #3359.

SBI Securities first reported a position in IMNM in Q4 2024 and has held it in 8 quarters since. The position peaked at $651 in Q2 2025. 18 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • SBI Securities held 11 shares of Immunome worth $237 as of Q3 2026.
  • SBI Securities bought 1 Immunome share in Q3 2026, an estimated $25.
  • Immunome made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3359 holding.
  • SBI Securities first reported a position in Immunome in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Immunome position peaked at $651 in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.